{
    "title": "COVID rebound after Pfizer treatment likely due to robust immune response, study finds",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11289055/COVID-rebound-Pfizer-treatment-likely-robust-immune-response-study-finds.html",
    "date": "2022-10-06",
    "keywords": [
        "rebound",
        "response",
        "study",
        "paxlovid",
        "team",
        "infection",
        "treatment",
        "leo",
        "julie",
        "immune",
        "course",
        "drug",
        "investigation",
        "return",
        "covid",
        "virus",
        "phase",
        "need",
        "covid19",
        "government",
        "thursday",
        "risk",
        "recurrence",
        "institutes",
        "center",
        "hypothesis",
        "reason",
        "replication",
        "president",
        "joe",
        "biden",
        "institute",
        "allergy",
        "director",
        "dr",
        "anthony",
        "medicine",
        "development",
        "recovery",
        "group",
        "version",
        "omicron",
        "variant",
        "blood",
        "improvement",
        "milder",
        "level",
        "severity",
        "none",
        "hospitalization",
        "respiratory",
        "tract",
        "symptom",
        "research",
        "data",
        "isolation",
        "reporting",
        "bengaluru",
        "steenhuysen",
        "chicago",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}